News and Trends 14 Feb 2020 Novozymes Launches Super Robust Yeast to Maximize Biofuel Production The Danish industrial biotech company Novozymes has announced the launch of its latest non-GM yeast technology, Innova Fit, which it says reduces biofuel production bottlenecks caused by conventional and basic yeast. Biofuels, including ethanol, are a renewable energy source being used as a replacement for fossil fuels, with substantially reduced CO2 emissions, particularly in the transport […] February 14, 2020 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 13 Feb 2020 French Partnership Deploys AI for Antibody Drug Discovery French companies OSE Immunotherapeutics and MAbSilico are teaming up to drive the discovery of new antibody drugs using artificial intelligence. The three-year partnership will use artificial intelligence, or AI, in six programs designed to accelerate the development of therapeutic monoclonal antibodies (mAbs) that can target cancer and autoimmune diseases. AI can improve the efficiency of […] February 13, 2020 - 2 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 10 Feb 2020 Meiogenix, Bayer Team Up to Boost Genetic Diversity in Crop Breeding Bayer and the French biotech company Meiogenix will work together to advance the development of Meiogenix’s plant breeding and genome editing technologies with the hope of improving food crops for farmers. For many years, the only way to improve characteristics such as yield and nutritional value of crops was through selective breeding, which can be […] February 10, 2020 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 6 Feb 2020 Lunaphore Raises €21.5M to Develop Automated Cancer Research Tools Swiss company Lunaphore Technologies has raised €21.5M (CHF 23M) in Series C funding to expand the automation of cancer research and tissue diagnostics in Europe and the US. The oversubscribed funding round was completed in mid-January and was led by Japan-based PHC Holdings Corporation, with further contributions from existing investors including Redalpine Venture Partners, OCCIDENT […] February 6, 2020 - 2 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 6 Feb 2020 Camena Bioscience Hits DNA Synthesis Milestone Camena Bioscience has achieved a significant DNA synthesis milestone by reproducing the DNA sequence of a whole plasmid, which could be used in synthetic biology applications such as protein production and bacterial engineering. DNA synthesis is a field that, until recently, had not been a focus for companies developing innovative technologies, with greater importance being […] February 6, 2020 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 5 Feb 2020 MaaT Pharma’s Microbiome Cancer Treatment Given €18M Boost French company MaaT Pharma has raised €18M in Series B financing that will support phase Ib and II trials of its biotherapeutic drug, which aims to restore the microbiome and improve outcomes in patients with various types of blood cancer and solid tumors. The financing round included French microbiome-focused investor Symbiosis, as well as support […] February 5, 2020 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Startup Scout 24 Jan 2020 This Company is Using Moths to Make Vaccines Madrid-based company Algenex is using moths as natural bioreactors to improve the speed and scalability of making proteins used in vaccines and diagnostics. Mission: To harness nature for simple, scalable, and cost-efficient recombinant protein manufacture. While many proteins are manufactured using bacteria, some are made using insect cells because these cells are sometimes better […] January 24, 2020 - 4 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 18 Jan 2020 DNA Data Storage Project Receives €20.7M from US Intelligence Agency A DNA data storage project, involving French biotech DNA Script, has been awarded a contract worth up to €20.7M from the US Intelligence Advanced Research Projects Activity agency to develop a prototype instrument able to store and retrieve 1 terabyte of information in 24 hours. The Molecular Encoding Consortium, led by Robert Nicol at the Broad […] January 18, 2020 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 16 Jan 2020 Biotech Investment Firm Jeito Capital Launches with €200M Fund The French investment firm Jeito Capital has launched this week with a €200M fund that will support up to 15 drug-development start-ups with a focus on European companies. Jeito Capital is the brainchild of Rafaèle Tordjman, whose background in medicine and research as well as investment in life sciences led her to setting up the […] January 16, 2020 - 2 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 9 Jan 2020 Emergex Vaccines Secures €10M to Advance Synthetic Vaccine Development The UK biotech Emergex Vaccines has raised over €9.9M in a Series A funding round, which will allow it to progress the development of vaccines against diseases such as dengue, influenza, and Ebola to phase I clinical trials. Emergex specializes in the development of ‘set-point’ vaccines, which company CEO and co-founder Thomas Rademacher describes as […] January 9, 2020 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 29 Nov 2019 Bioplastics Consortium Granted €25M EU Funding The PEFerence consortium, coordinated by Avantium Renewable Polymers, has received reconfirmation of a €25M Horizon 2020 grant from the Bio-based Industries Joint Undertaking to develop plant-based, recyclable plastics. The grant was originally awarded in 2017 when the PEFerence consortium was under coordination of Synvina, a joint venture between Avantium and BASF. This venture was dissolved […] November 29, 2019 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Sponsored 27 Nov 2019 How to Address the Challenges of Biologics Discovery and Development The biologics industry is growing at an incredible rate. While its global market value was estimated at $236B in 2017, it is expected to rise to $310B by 2023. As key market players enter the field, competition is increasing. In recent years, the biologics industry has become more versatile and has moved from being primarily […] November 27, 2019 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email